New inhaled drug KIT2014 tested for COPD – early trial begins
Disease control
Not yet recruiting
This study tests an inhaled drug called KIT2014 in 36 adults with moderate to severe COPD. Participants will receive either the drug or a placebo daily for 7 days. The main goal is to check safety and how the body handles the drug, with a first look at whether it might help breat…
Phase: PHASE1, PHASE2 • Sponsor: Kither Biotech Srl • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC